These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2946924)

  • 1. Recombinant hepatitis B vaccine.
    Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924
    [No Abstract]   [Full Text] [Related]  

  • 2. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 3. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and serological evaluation of preventive vaccination of volunteers of the high risk group with hepatitis B vaccine].
    Brzosko WJ; Laskowski ZK; Bańkowski A; Janicki P; Dabrowa A; Tkacz B; Gall W
    Pol Tyg Lek; 1986 Jul; 41(28):893-5. PubMed ID: 2945170
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on hepatitis B prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Jun; 36(23):353-60, 366. PubMed ID: 2953959
    [No Abstract]   [Full Text] [Related]  

  • 6. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B vaccines.
    Troisi CL; Hollinger FB
    Prog Liver Dis; 1990; 9():405-42. PubMed ID: 2156306
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine: issues, recommendations, and new developments.
    Stevens CE; Taylor PE
    Semin Liver Dis; 1986 Feb; 6(1):23-7. PubMed ID: 2940687
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on hepatitis B prevention. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Sep; 107(3):353-7. PubMed ID: 3039889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of small dosage of intradermal inoculation of hepatitis B vaccine in infants].
    Liu X
    Zhonghua Hu Li Za Zhi; 1992 Mar; 27(3):110-2. PubMed ID: 1596949
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
    Horejsí J
    Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of pre-S2 peptide of hepatitis B virus: should it be in the vaccine?
    Hellström UB; Sylvan SP
    Prog Med Virol; 1988; 35():76-106. PubMed ID: 2971987
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B vaccination].
    Genescá Ferrer J; Esteban Mur R
    Rev Clin Esp; 1986 Mar; 178(5):207-9. PubMed ID: 2940650
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
    Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
    Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.